Risk of gout flares after vaccination: a prospective case cross-over study.

Annals of the Rheumatic Diseases
Chio YokoseHyon Choi

Abstract

The recombinant zoster vaccine (RZV) containing a strong non-aluminium adjuvant is associated with increased risk of gout flares, presumably via NLRP3 inflammasome activation. We tested the possibility that other vaccines may also be associated with gout flares. We conducted an online case-crossover study of patients with gout to examine the association between vaccination and gout flares. We collected information through the Internet on exposures to potential risk factors, including vaccinations, during 2-day hazard periods prior to gout flare and 2-day control periods without a flare. Conditional logistic regression was used to adjust for covariates. There were 517 participants with gout (mean age 55 years, 79% male) who experienced gout flares during follow-up. There were 28 vaccinations during 990 hazard periods and 21 vaccinations during 1407 control periods. Vaccination was associated with twofold higher odds of gout flare (adjusted OR 1.99; 95% CI 1.01 to 3.89). Our findings suggest vaccines other than RZV are associated with increased odds of gout flares, potentially through a shared pathogenetic mechanism like NLRP3 inflammasome. However, the absolute magnitude of increased odds of gout flares with vaccinations remains...Continue Reading

References

Apr 1, 1977·Arthritis and Rheumatism·S L WallaceT F Yü
Aug 30, 2003·BMJ : British Medical Journal·Tim McAlindonMelissa Lehmer
Jan 13, 2006·Nature·Fabio MartinonJürg Tschopp
Dec 13, 2006·Journal of Clinical Epidemiology·Yuqing ZhangDavid T Felson
Jan 25, 2012·Pharmacoepidemiology and Drug Safety·Malcolm MaclureDavid Madigan
May 26, 2012·The American Journal of Medicine·Yanyan ZhuHyon K Choi
Oct 11, 2013·Annals of the Rheumatic Diseases·Pascal RichetteThomas Bardin
Jan 17, 2014·Annals of the Rheumatic Diseases·Chang-Fu KuoMichael Doherty
Jun 14, 2014·Nature Reviews. Immunology·Ennio De Gregorio, Rino Rappuoli
Apr 29, 2015·The New England Journal of Medicine·Himal LalUNKNOWN ZOE-50 Study Group
Jul 8, 2015·Nature Reviews. Rheumatology·Chang-Fu KuoMichael Doherty
Sep 15, 2016·The New England Journal of Medicine·Anthony L CunninghamUNKNOWN ZOE-70 Study Group
Apr 19, 2017·Clinical Therapeutics·Corrado BlandizziGiovanni Lapadula
Nov 22, 2017·Arthritis & Rheumatology·Angelo L GaffoWilliam Taylor
Jan 2, 2018·The Application of Clinical Genetics·Berish Y Rubin, Sylvia L Anderson
Jan 26, 2018·MMWR. Morbidity and Mortality Weekly Report·Kathleen L DoolingRafael Harpaz
Apr 20, 2019·Current Opinion in Immunology·Thomas C HeinemanMyron Levin

❮ Previous
Next ❯

Citations

Dec 27, 2019·Current Opinion in Rheumatology·Nicholas A SumpterTony R Merriman
Feb 17, 2021·The Medical Clinics of North America·Cassandra Calabrese
Apr 3, 2021·Lancet·Nicola DalbethAbhishek Abhishek
Feb 10, 2021·Rheumatology·Tiphaine LenfantCassandra Calabrese
Aug 20, 2019·Annals of the Rheumatic Diseases·Shih-Wei LaiKuan-Fu Liao
Dec 4, 2019·Annals of the Rheumatic Diseases·Arnaud M DidierlaurentAnthony L Cunningham

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.